Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
LifeMD (LFMD)
NASDAQ:LFMD
LifeMD (LFMD) Stock Price & Analysis
434 Followers
LFMD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.45 - $12.88
Previous Close$6.77
Volume357.97K
Average Volume (3M)922.92K
Market Cap
$282.69M
Enterprise Value$269.63M
Total Cash (Recent Filing)$35.11M
Total Debt (Recent Filing)$19.90M
Price to Earnings (P/E)―
Beta1.97
Next Earnings
Aug 08, 2024EPS Estimate
-$0.14Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.74
Shares Outstanding42,289,990
10 Day Avg. Volume881,773
30 Day Avg. Volume922,917
Standard Deviation0.48
R-Squared0.02
Alpha0.09
Financial Highlights & Ratios
Price to Book (P/B)-26.05
Price to Sales (P/S)1.93
Price to Cash Flow (P/CF)12.90
P/FCF Ratio16.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.65
Enterprise Value/Gross Profit2.02
Enterprise Value/Ebitda-100.86
Forecast
1Y Price Target
$12.60Price Target Upside81.03% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
LifeMD News
Bulls Say, Bears Say
Bulls Say
Gross MarginsLFMD reported record gross margins for the 8th consecutive quarter, driven by strong performance in telehealth margins.
Insurance ContractsExpanding insurance contracts are paving the way to Medicare coverage, starting with an initial launch on a limited-state basis.
Weight ManagementLifeMD's weight management has demonstrated robust growth, adding 20k subscribers in 1Q and bringing the total to 42k at the end of 1Q.
Bears Say
CompetitionNew market entrants like Costco's partnership with Sesame Health indicate increasing competition in the telehealth and weight loss drug market.
Financial PerformanceWorkSimpli 4Q revenue declining by -4.7% to $13.6M.
Product LaunchLLY's launch of their own end-to-end digital healthcare platform, LillyDirect, provides similar services to LFMD's weight management business.
---
Ownership Overview
24.34% Insiders
5.87% Mutual Funds
8.42% Other Institutional Investors
61.37% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Ability to SellRisks related to the company’s ability to sell goods and services
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
LFMD FAQ
What was LifeMD’s price range in the past 12 months?
LifeMD lowest stock price was $3.45 and its highest was $12.88 in the past 12 months.
What is LifeMD’s market cap?
Currently, no data Available
When is LifeMD’s upcoming earnings report date?
LifeMD’s upcoming earnings report date is Aug 08, 2024 which is in 13 days.
How were LifeMD’s earnings last quarter?
LifeMD released its earnings results on May 08, 2024. The company reported -$0.19 earnings per share for the quarter, missing the consensus estimate of -$0.154 by -$0.036.
Is LifeMD overvalued?
According to Wall Street analysts LifeMD’s price is currently Undervalued.
Does LifeMD pay dividends?
LifeMD does not currently pay dividends.
What is LifeMD’s EPS estimate?
LifeMD’s EPS estimate is -$0.14.
How many shares outstanding does LifeMD have?
LifeMD has 41,756,530 shares outstanding.
What happened to LifeMD’s price movement after its last earnings report?
LifeMD reported an EPS of -$0.19 in its last earnings report, missing expectations of -$0.154. Following the earnings report the stock price went down -24.574%.
Which hedge fund is a major shareholder of LifeMD?
Among the largest hedge funds holding LifeMD’s share is Royce & Associates LLC. It holds LifeMD’s shares valued at 8M.
---
LifeMD Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$12.60 (81.03% Upside)
$12.60 (81.03% Upside)
Blogger Sentiment
Bullish
LFMD Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 34.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 3.9%
Last 30 Days ▼ 3.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
80.05%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
81.45%
Trailing 12-Months
Company Description
LifeMD
Conversion Labs, Inc. engages in the manufacturing, distribution, and sale of natural immune support products containing proprietary yeast beta glucans. Its products are oral intake tablets and topical creams, and gels for skin application. It operates through the Finished Cosmetic Products and Nutraceutical and Cosmetic Additives segments. The company was founded in 1987 and is headquartered in New York, NY.
---
LFMD Company Deck
---
LFMD Earnings Call
Q1 2024
0:00 / 0:00
---
LFMD Stock 12 Month Forecast
Average Price Target
$12.60
▲(81.03% Upside)
Technical Analysis
Best Analysts Covering LFMD
1 Year
1 Year Success Rate
9/28 ratings generated profit
1 Year Average Return
+23.31%
reiterated a buy rating 3 months ago
Copying David Larsen's trades and holding each position for 1 Year would result in 32.14% of your transactions generating a profit, with an average return of +23.31% per trade.
---